CYP17 polymorphism and hot flushes in postmenopausal women

Climacteric

Volumn 11, Issue 5, 2008, Pages 404-408

  Massad Costa, A M ^a,c   Nogueira De Souza, N C ^a   De Carvalho, C V ^a   Da Silva, I D ^a   Guindalini, C ^a   Nogueira Jr , R C ^a   Soares Jr , J M ^a   Haidar, M A ^a   Baracat, E C ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

CYP17 ; Hot flush; Polymorphism; Postmenopause

Indexed keywords

CYTOCHROME P450 17;

ADULT; ARTICLE; CARDIOVASCULAR SYMPTOM; DISEASE SEVERITY; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

FEMALE; GENE FREQUENCY; GENOTYPE; HOT FLASHES; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; STEROID 17-ALPHA-HYDROXYLASE;

EID: 51649094310     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130802395026     Document Type: Article

References (27)

1. Takeo C, Negishi E, Nakajima A, et al. Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms. Gend Med 2005;2:96-105
2. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86
3. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 2003;74:67-83
4. Stocco D, Clark B. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996;17:221-44
5. Dunning A, Dowsett M, Healey C, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004;96:936-45
6. Picado-Leonard J, Miller W. Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxiylase/17,20 lyase): similarity with the gene for P450c21. DNA 1987;6:439-48
7. Sharp L, Cardy A, Cotton S, Little J. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. AHuGE Review. Am J Epidemiol 2004;160:729-40
8. Haiman C, Hankinson S, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999;59:1015-20
9. Nagle C, Chenevix-Trench G, Webb P, Spurdle A. Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes. Cancer Lett 2007;18:96-104
10. Campbell P, Edwards L, Mclaughlin J, Green J, Younghusband H, Woods M. Cytochrome P450 17A1 and catechol O-methyltransferase polymorphisms and age at Lynch syndrome colon cancer onset in Newfoundland. Clin Cancer Res 2007;13:3783-8
11. Hamada A, Danesi R, Price D, et al. Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgenin-dependent prostate cancer. Urology 2007;70:217-20
12. Gaudet M, Lacey J, Lissowska J, et al. Genetic variation in CYP17 and endometrial cancer risk. Hum Genet 2008;123:155-62
13. Chen Y, Gammon M, Teitelbaum S, et al. Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project. Carcinogenesis 2008;29:766-71
14. Carey A, Waterworth D, Patel K, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994;3:1873-6
15. Feigelson H, Mckean-Cowdin R, Pike M, et al. Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res 1999;59:3908-10
16. Freeman E, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197-214
17. Overlie I, Moen M, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 2002;41:69-77
18. Guthrie J, Dennerstein L, Taffe J, Lehert P, Burger H. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 2005;12:460-7
19. Randolph J, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90:6106-12
20. Maclennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric 2001;4:58-74
21. Nelson H. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;291:1610-20
22. Simpson E, Clyne C, Rubin G, et al. Aromatase - a brief overview. Annu Rev Physiol 2002;64:93-127
23. Tempfer C, Schneeberger C, Huber J. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57-65
24. Mitchell E, Farin F, Stapleton P, et al. Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition. Menopause 2008;15:105-11
25. Feigelson H, Shames L, Pike M, Coetzee G, Stanczyk F, Henderson B. Cytochrome P450c17{alpha} gene (CYP17) polymorphism is associated with serum oestrogen and progesterone concentration. Cancer Res 1998;58:585-87
26. Haiman C, Hankinson S, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999;59:1015-20
27. Visvanathan K, Gallicchio L, Schilling C, et al. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol 2005;106:1372-81